Monoclonal antibodies production

CliniSciences has a widely recognized expertise in generating monoclonal antibodies from mice and rats with high affinity and specificity.

The development of monoclonal antibodies is primarily based on two technological approaches: hybridomas or Phage Display (recombinant antibodies).

Each monoclonal antibody development project is structured into several phases, allowing the client to test the results at each stage and decide whether to continue the project (Go/No Go).